ABSTRACT Hybridization of human T cells with an azaguanine-resistant human T cell line gave rise to T hybrid cell lines secreting several immunoregulatory molecules. Analyses ofkaryotypes, HLA phenotypes, and other surface phenotypes, such as T-cell-specific antigens or receptors for sheep erythrocytes and the patterns of mitogen responsiveness confirmed that the hypoxanthine/aminopterin/thymidine-resistant cell lines were human T-T hybridomas. One of the established hybrid clones (24-A) secreted human interleukin-2 (IL-2). The culture supernatants induced the proliferation of concanavalin A-stimulated murine T cells and supported the proliferation ofan IL-2-dependent human cytotoxic T-cell line. In a clone (38-B) that did not show any L-2 activity in culture supernatants, the addition of macrophages induced IL-2 production in the presence of phytohemagglutinin, suggesting that interleukin-l induced IL-2 production in T hybrid cells. Hybrid cells secreting killer helper factor were also established. The culture supernatants from this clone, 55-A, helped the induction ofcytotoxic T cells against UV-treated human B-blastoid cells but did not show any IL-2 activity.
Application of cell-hybridization techniques to murine T lymphocytes has resulted in T hybrid cell lines that have several immunological activities-i.e., T hybridomas secreting IgE class-specific suppressor factor (1), antigen-specific suppressor factor (2), T-cell replacing factor (3) , and the factor(s) responsible for the proliferation of T lymphocytes (interleukin-2; IL-2) (4). Homogeneous populations of such hybridomas capable of immune functions have obviously facilitated the isolation and chemical characterization of T-cell-derived immunoregulatory molecules.
Establishment of human T hybridomas should lead to production of purified lymphokines to allow more rapid progress in their chemical and biological characterization and exploration of their clinical potential. Thus, we attempted to establish human T hybrid cells by using an azaguanine-resistant mutant of a human leukemic T-cell line, CEM-AGR, as a parental cell line. The results show that hybridization ofhuman peripheral T cells with CEM-AGR cells gives rise to human T-T hybridomas that secrete immunoregulatory molecules. One of several hybrid clones secretes human IL-2, which is effective in maintaining an IL-2 dependent human eytotoxic T-cell line, and the other clone produces helper factor(s) effective in the differentiation of cytotoxic T cells.
MATERIALS AND METHODS Cell
Lines. An azaguanine-resistant mutant T-cell line sensitive to 0.1 mM hypoxanthine/0.4 ,AM aminopterin/16 AM thymidine; (Sigma) was selected from a human T-leukemic cell line (CCRF-CEM) (5) provided by J. Minowada (RPMI, Buffalo, NY) by culturing the cells with 8-azaguanine (Sigma) at gradually increasing concentration (2-100 ,uM over 8 weeks). The Epstein-Barr virus-tranformed human B-blastoid cell line, CESS, was a gift from P. Ralph.
Cell Preparations. T lymphocytes from human peripheral blood or tonsils were separated by rosette formation with neuraminidase-treated sheep erythrocytes as described (6 with HAT medium and incubation was continued for at least 4 weeks. Cloning of hybrid cells was performed by a limiting-dilution method. Measurement of Mitogenic Activity of Culture Supernatants. Mitogenic activity of culture supernatants 'as assessed by the promotion of Con A-induced mitogenesis in murine thymocytes according to, the method of Shaw et aL (7) .
Assay for IL-2 Activity. Activity of human IL-2 in culture supernatants from T hybridomas was measured by an assay system similar to that described by Gillis et aL (8 (Fig. 1) . The parental cell line CEM-AGR did not produce mitogenic factors even after stimulation with Con A.
As shown in Fig. 2 , the Mr 13,000-20,000 fraction from the culture supernatant from 24-A cells could maintain the proliferation of an IL-2-dependent human cytotoxic T-cell line and the activity was dependent on the concentration of the factor. The fraction with the same molecular weight as the parental cell line CEM-AGR did not show any IL-2 activity on a cytotoxic Tcell line at any concentration. The molecular weight ofthe factor with IL-2 activity from a hybrid clone was in close agreement with the Mr 15,000 of human T-cell-derived IL-2 reported by Gillis et aL (11). Table 4 , the coculture of normal T cells and UV-treated CESS cells did not induce any cytotoxic T cells against CESS cells. On the other hand, the addition of culture supernatants from hybrid clone 55-A permitted the induction of cytotoxic T cells in the coculture of normal T cells and UV-treated CESS cells. The activity ofcytotoxic T cells induced by the addition of the culture supernatants from 55-A cells was comparable with that induced by the addition of culture supernatants from a MLC reaction. The culture supernatants from 55-A cells, which showed the helper effect on the induction of cytotoxic T cells, did not show any IL-2 activity when tested by using an IL-2-dependent cytotoxic T-cell line. These results suggested that clone 55-A produced a killer helper factor(s) that was distinct from IL-2. Not only Con A-induced production of IL-2 in the hybrid clone 24-A but also macrophage-induced production of IL-2 in another hybrid clone, 38-B, was shown. In a murine system, it has been reported that adherent cell-depleted spleen cells failed to produce IL-2 from splenic T cells by stimulation with Con A and that production of IL-2 was restored by the addition of macrophages or their products, IL-1 (12) . Gillis The culture supernatants from T hybrid clone 55-A helped the induction of cytotoxic T lymphocytes (CTL) in the primary MLC using UV-treated stimulator cells. Interestingly, however, IL-2 activity could not be detected in the supernatants when examined by using an IL-2-dependent human cytotoxic T-cell line or Con A-stimulated murine thymocytes. In the analysis of soluble factor(s) involved in the generation ofCTL, it has been suggested that IL-2 is essential for the induction of CTL (14, 15) . On the other hand, Farrar et at (16) suggested that another soluble factor(s), immune-interferon, had helper activity in the generation of CTL and that IL-2 was required for the production of immune-interferon. The supernatants from 55-A cells showed helper activity in the induction of CTL but little IL-2 activity, suggesting that the hybrid cells produced factor(s) distinct from IL-2, which were effective mainly on differentiation of CTL. However, another possibility might be considered-i.e., the supernatants from 55-A cells might induce IL-2 production in T-cell populations involved in primary MLC. Actually, it has been suggested that supernatants from a macrophage tumor cell line (17, 18) can induce the primary CTL responses via IL-2 production.
Another approach for the large-scale purification of IL-2 has been reported by Gillis and Watson (19) . They screened a large number of human leukemic T-cell lines for the production of IL-2 and found one, Jurkat-FHCRC, that was capable of secreting IL-2 after stimulation with Con A or PHA. No doubt this cell line will facilitate the chemical characterization of IL-2. However, it may be impossible to find T leukemic cell lines that produce several other lymphokines such as killer helper factor(s) or T-cell replacing factor. In such circumstances, the establishment ofhuman T hybridomas should provide a tool for obtaining T-cell clones producing several different human immunoregulatory molecules. These may be applicable for the management and treatment ofdisorders in immune regulation, including immunodeficiency diseases, autoimmune diseases, immediate type hypersensitivity, and some types of cancer.
